Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Board/Management Information 2009

Feb 18, 2009

29745_rns_2009-02-18_1a09a73e-0fda-42f5-a068-172b2736e126.zip

Board/Management Information

Open in viewer

Opens in your device viewer

8-K 1 htm_31426.htm LIVE FILING CoverPageHeader start html PUBLIC "-//W3C//DTD HTML 3.2//EN" Eli Lilly and Company (Form: 8-K) Comment1

CoverPageHeader end CoverPageTitle START

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): February 17, 2009

CoverPageTitle END CoverPageRegistrant START

Eli Lilly and Company ______ (Exact name of registrant as specified in its charter)

Indiana 001-06351 35-0470950
___ (State or other jurisdiction _______ (Commission __ (I.R.S. Employer
of incorporation) File Number) Identification No.)
Lilly Corporate Center, Indianapolis, Indiana 46285
_________ (Address of principal executive offices) _____ (Zip Code)

Registrant’s telephone number, including area code: 317-276-2000

Not Applicable __________ Former name or former address, if changed since last report

CoverPageRegistrant END

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

PageBreak START

Top of the Form

PageBreak END Item START

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On February 17, 2009, the Board of Directors of Eli Lilly and Company elected Ralph Alvarez as a new member, effective April 1, 2009. Alvarez, 53, currently serves as president and chief operating officer of McDonald’s Corporation. As a member of Lilly’s board, Alvarez will serve on the board’s finance committee and public policy and compliance committee. He will serve under interim election and will stand for election by Lilly shareholders at the company’s annual meeting in 2010. Mr. Alvarez has served as president and COO of McDonald’s Corporation since August 2006. He joined McDonald’s in 1994 and has held a variety of leadership roles throughout his career, including president of McDonald’s North America and president and chief operations officer of McDonald’s USA. Prior to joining McDonald’s, Alvarez had a lengthy career in the restaurant industry working for Burger King Corporation and Wendy’s International, Inc. He is a director of McDonald's Corporation and KeyCorp.

Item END

PageBreak START

Top of the Form

PageBreak END SignatureHeader START

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

SignatureHeader END Signature START

James B. Lootens
Name: James B. Lootens
Title: Secretary and Deputy General Counsel

Signature END HTMLFooter START HTMLFooter END